CME Group Inc. (CME) Position Decreased by Alley Co LLC
Alley Co LLC reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 2.7% during the second quarter, Holdings Channel reports. The institutional investor owned 36,365 shares of the company’s stock after selling 1,000 shares during the period. CME Group accounts for 1.6% of Alley Co LLC’s holdings, making the stock its 28th largest position. Alley Co LLC’s holdings in CME Group were worth $3,542,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. Geode Capital Management LLC boosted its stake in CME Group by 6.0% in the first quarter. Geode Capital Management LLC now owns 2,947,602 shares of the company’s stock worth $282,588,000 after buying an additional 167,225 shares in the last quarter. Primecap Management Co. CA boosted its stake in CME Group by 6.5% in the first quarter. Primecap Management Co. CA now owns 1,946,113 shares of the company’s stock worth $186,924,000 after buying an additional 118,150 shares in the last quarter. Legal & General Group Plc boosted its stake in CME Group by 2.0% in the first quarter. Legal & General Group Plc now owns 1,391,482 shares of the company’s stock worth $133,643,000 after buying an additional 27,322 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in CME Group by 4.6% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,137,234 shares of the company’s stock worth $110,767,000 after buying an additional 50,334 shares in the last quarter. Finally, Bank of Montreal Can bought a new stake in CME Group during the second quarter worth approximately $35,643,000. Institutional investors and hedge funds own 79.89% of the company’s stock.
CME Group Inc. (NASDAQ:CME) traded down 1.62% during midday trading on Monday, reaching $103.73. The company’s stock had a trading volume of 879,846 shares. The stock has a 50 day moving average of $106.48 and a 200 day moving average of $99.70. CME Group Inc. has a 52 week low of $81.87 and a 52 week high of $110.35. The firm has a market capitalization of $35.15 billion, a PE ratio of 26.19 and a beta of 0.83.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.03. The company earned $906 million during the quarter, compared to the consensus estimate of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.95 EPS. On average, equities research analysts predict that CME Group Inc. will post $4.43 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.29%. CME Group’s dividend payout ratio (DPR) is presently 60.61%.
A number of analysts have issued reports on the company. Deutsche Bank AG raised their price target on CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Jefferies Group reissued a “buy” rating and issued a $118.00 price target on shares of CME Group in a research note on Thursday. JPMorgan Chase & Co. raised their price target on CME Group from $99.00 to $106.00 and gave the stock an “overweight” rating in a research note on Friday, July 29th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, June 30th. Finally, Credit Agricole SA reduced their price objective on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a research note on Thursday, July 14th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $103.27.
In other news, insider Bryan T. Durkin sold 15,000 shares of the company’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $107.75, for a total transaction of $1,616,250.00. Following the completion of the sale, the insider now owns 63,967 shares in the company, valued at approximately $6,892,444.25. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Ronald A. Pankau sold 400 shares of the company’s stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $103.32, for a total value of $41,328.00. Following the sale, the director now owns 4,382 shares of the company’s stock, valued at approximately $452,748.24. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.